Nestle extends pharma push with new bet on gut drugs

April 20 (Reuters) - Nestle has extended its push

into medicine with a small investment in a biotech company

developing a drug designed to fight inflammatory bowel disease

by restoring a healthy bacteria balance in the gut.

Read more